Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 12CNS 7Other solid neoplasm 4Genitourinary 4Other hematologic neoplasm 3Lymphoid 3Gastrointestinal 3Myeloid 2Plasma cell 1Gynecologic 1Dermatologic 1Classical hematology 1

Conditions

Multiple Myeloma 83Neoplasms, Plasma Cell 54Leukemia 47Precursor Cell Lymphoblastic Leukemia-Lymphoma 45Lymphoma 45Hodgkin Disease 45Myelodysplastic Syndromes 44Lymphoma, Non-Hodgkin 43Leukemia, Myeloid, Acute 43Leukemia, Lymphocytic, Chronic, B-Cell 43Lymphoma, Follicular 35Lymphoma, Large B-Cell, Diffuse 34Lymphoma, Mantle-Cell 32Lymphoma, B-Cell, Marginal Zone 32Lymphoma, Large-Cell, Immunoblastic 31Leukemia, Myeloid, Chronic-Phase 30Congenital Abnormalities 30Burkitt Lymphoma 30Primary Myelofibrosis 27Myeloproliferative Disorders 27Leukemia, Myeloid, Accelerated Phase 27Leukemia, Myelomonocytic, Chronic 24Blast Crisis 24Recurrence 21Lymphoma, T-Cell, Cutaneous 18Dendritic Cell Sarcoma, Interdigitating 18Waldenstrom Macroglobulinemia 17Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative 17Myelodysplastic-Myeloproliferative Diseases 16Pdgfra-Associated Chronic Eosinophilic Leukemia 14

Interventions

selinexor 2pazopanib 2Radiotherapy 2Injections 2Ifosfamide 2Filgrastim 2Doxorubicin 2Cyclophosphamide 2sargramostim 1resiquimod 1repotrectinib 1poly ICLC 1interferon-alfa-1b 1cc-486 1aldesleukin 1Voriconazole 1Thalidomide 1Suspensions 1Rituximab 1Radiation 1Quality of Life 1Proton Therapy 1Peripheral Blood Stem Cell Transplantation 1Pentetic Acid 1Patient Reported Outcome Measures 1Molecular Diagnostic Techniques 1Minocycline 1Methotrexate 1Melphalan 1Magnetic Resonance Spectroscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sarcoma × Busulfan × Plasma cell × Clear all
NCT00253552 2012-05-28

G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic Disorders

OHSU Knight Cancer Institute

Phase NA Terminated
4 enrolled
DermatologicLymphoidMyeloidOther hematologic neoplasmPlasma cellSarcoma

Pdgfra-Associated Chronic Eosinophilic Leukemia, Congenital Abnormalities, Blast Crisis, Burkitt Lymphoma, Graft vs Host Disease, Hodgkin Disease, Leukemia, Leukemia, Hairy Cell, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Multiple Myeloma, Mycosis Fungoides, Myelodysplastic Syndromes, Myeloproliferative Disorders, Recurrence, Sarcoma, Sezary Syndrome, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Neutrophilic, Chronic, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, T-Cell, Cutaneous, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Leukemia, Myelomonocytic, Juvenile, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Dendritic Cell Sarcoma, Interdigitating, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡